skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Blood remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Seibel, Nita L. ; Steinherz, Peter G. ; Sather, Harland N. ; Nachman, James B. ; DeLaat, Cynthia ; Ettinger, Lawrence J. ; Freyer, David R. ; Mattano, Leonard A. ; Hastings, Caroline A. ; Rubin, Charles M. ; Bertolone, Kathy ; Franklin, Janet L. ; Heerema, Nyla A. ; Mitchell, Torrey L. ; Pyesmany, Allan F. ; La, Mei K. ; Edens, Cheryl ; Gaynon, Paul S.

Blood, 2008-03, Vol.111 (5), p.2548-2555 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Bostrom, Bruce C. ; Sensel, Martha R. ; Sather, Harland N. ; Gaynon, Paul S. ; La, Mei K. ; Johnston, Katherine ; Erdmann, Gary R. ; Gold, Stuart ; Heerema, Nyla A. ; Hutchinson, Raymond J. ; Provisor, Arthur J. ; Trigg, Michael E.

Blood, 2003-05, Vol.101 (10), p.3809-3817 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Lange, Beverly J. ; Bostrom, Bruce C. ; Cherlow, Joel M. ; Sensel, Martha G. ; La, Mei K.L. ; Rackoff, Wayne ; Heerema, Nyla A. ; Wimmer, Robert S. ; Trigg, Michael E. ; Sather, Harland N.

Blood, 2002-02, Vol.99 (3), p.825-833 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group
Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group

Heerema, Nyla A. ; Nachman, James B. ; Sather, Harland N. ; Sensel, Martha G. ; Lee, Mei K. ; Hutchinson, Raymond ; Lange, Beverly J. ; Steinherz, Peter G. ; Bostrom, Bruce ; Gaynon, Paul S. ; Uckun, Fatih

Blood, 1999-12, Vol.94 (12), p.4036-4045 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Survival after Relapse in Higher Risk Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents Is Independent of Prior Treatment Intensity: A Report from the Children's Oncology Group (COG)
Survival after Relapse in Higher Risk Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents Is Independent of Prior Treatment Intensity: A Report from the Children's Oncology Group (COG)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Survival after Relapse in Higher Risk Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents Is Independent of Prior Treatment Intensity: A Report from the Children's Oncology Group (COG)

Freyer, David Robert ; Seibel, Nita L. ; La, Mei K ; Devidas, Meenakshi ; Carroll, William L. ; Hunger, Stephen P. ; Gaynon, Paul S.

Blood, 2008-11, Vol.112 (11), p.917-917 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
6
Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children's Oncology Group Study 1991
Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children's Oncology Group Study 1991
Material Type:
Artigo 		Adicionar ao Meu Espaço

Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children's Oncology Group Study 1991

Matloub, Yousif ; Bostrom, Bruce C. ; Hunger, Stephen P. ; Angiolillo, Anne L ; Cole, Catherine ; Thomson, Blythe ; Devidas, Meenakshi ; Heerema, Nyla A. ; La, Mei K ; Buckley, Patrick J. ; Carroll, William L. ; Winick, Naomi ; Sather, Harland ; Nachman, James B ; Gaynon, Paul S.

Blood, 2008-11, Vol.112 (11), p.9-9 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy
Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy

Cho, Robert ; Stork, Linda C. ; Gaynon, Paul S. ; Sather, Harland N. ; La, Mei K. ; Hutchinson, Raymond J.

Blood, 2005-11, Vol.106 (11), p.867-867 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
8
Outcome after Relapse among Children with Standard Risk (SR) ALL Treated on CCG-1952
Outcome after Relapse among Children with Standard Risk (SR) ALL Treated on CCG-1952
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcome after Relapse among Children with Standard Risk (SR) ALL Treated on CCG-1952

Malempati, Suman ; Gaynon, Paul S. ; Sather, Harland ; La, Mei K. ; Stork, Linda C.

Blood, 2004-11, Vol.104 (11), p.520-520 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
9
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
Material Type:
Artigo 		Adicionar ao Meu Espaço

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

Kollman, Craig ; Spellman, Stephen R. ; Zhang, Mei-Jie ; Hassebroek, Anna ; Anasetti, Claudio ; Antin, Joseph H. ; Champlin, Richard E. ; Confer, Dennis L. ; DiPersio, John F. ; Fernandez-Viña, Marcelo ; Hartzman, Robert J. ; Horowitz, Mary M. ; Hurley, Carolyn K. ; Karanes, Chatchada ; Maiers, Martin ; Mueller, Carlheinz R. ; Perales, Miguel-Angel ; Setterholm, Michelle ; Woolfrey, Ann E. ; Yu, Neng ; Eapen, Mary

Blood, 2016-01, Vol.127 (2), p.260-267 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

Louis, Chrystal U. ; Savoldo, Barbara ; Dotti, Gianpietro ; Pule, Martin ; Yvon, Eric ; Myers, G. Doug ; Rossig, Claudia ; Russell, Heidi V. ; Diouf, Oumar ; Liu, Enli ; Liu, Hao ; Wu, Meng-Fen ; Gee, Adrian P. ; Mei, Zhuyong ; Rooney, Cliona M. ; Heslop, Helen E. ; Brenner, Malcolm K.

Blood, 2011-12, Vol.118 (23), p.6050-6056 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1998  (13)
  2. 1998Até2004  (20)
  3. 2005Até2010  (21)
  4. 2011Até2017  (20)
  5. Após 2017  (29)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.